Intrivo and CareStart™

CareStart™ COVID-19 tests assess the current or past presence of SARS-CoV-2 and are manufactured in the United States for Intrivo.

CareStart is manufactured by Access Bio for Intrivo

Thank You!  
One of our dedicated team members will contact you promptly.
Oops! Something went wrong while submitting the form.
This form is intended for sale and distribution of CareStart tests to distributors, clinics, and medical professionals. CareStart is not a clinic or facility and does not provide on site testing services. For at home tests, please visit letsongo.com
Detect COVID-19 infection in as little as 10 minutes. Our rapid antigen test is a must-have at the point-of-care, bringing immediate, actionable results when you need them.
Our products demonstrate significant testing accuracy in the fight against COVID-19. The PPA and NPA of our tests can be found in the IFUs.
A true game-changer in answering the call for additional, rapid testing capacity – your care starts here!

About Intrivo

Intrivo is a digital health company and the exclusive commercialization partner for the CareStart™ line of COVID-19 testing products, manufactured by Access Bio. Together with Access Bio, we bring two decades of industry-leading experience in biosensor and in vitro diagnostics products to develop multiple flexible solutions that facilitate SARS-CoV-2 testing.

To learn more about our technology-driven health capabilities, visit intrivo.com today.

Our Vision

CareStart™ is a suite of diagnostic products offering easy to use, accurate and sophisticated testing. Supporting our mission to help save lives by preventing the spread of infectious diseases, the CareStart™ brand of diagnostic products are manufactured and rigorously tested in the United States. At a time of great need, we have combined our expertise in the early detection and diagnosis of infectious diseases with scalable logistics to power a seamless experience for our nation’s healthcare providers and patients.